Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Hochschild said it remains on track to meet its overall attributable production target of 291,000 to 319,000 gold-equivalent ounces. It is also expected to meet its all-in sustaining cost target of $1 ...

The U.K. international financial services business said Wednesday that group net receivables rose 14% to 1.01 billion pounds ($1.35 billion). It expects growth to continue to accelerate through the ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

As the brewer’s new chief executive settles into the job, TD Cowen analysts believe the company needs to do more than simply get leaner.

Shares of Warren Buffett’s Berkshire Hathaway have produced a bullish “golden cross” chart pattern, less than three months ...

Valuations are high, bear-market signposts are piling up, and companies are now contending with both tariff uncertainty and a ...

Jana said it plans to reach out to Six Flags’ board and management “regarding opportunities to enhance shareholder value and ...

U.S. stocks finished mixed on Tuesday with the Dow Jones Industrial Average booking a new all-time closing high as investors ...

A pioneer in AI pours cold water on hopes that the explosion of spending will lead to a productivity boost anytime soon.

Innovent Biologics is teaming up with Japan's Takeda Pharmaceutical to work on cancer therapies, a deal that could net the Chinese drugmaker up to US$11.4 billion.